Sabby Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Sabby Management’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-61,758	Closed	-$2.29K	–	54
2024 Q3	$2.29K	Sell	61,758 -290,326	-82%	-$64.9K	﹤0.01%	41
2024 Q2	$102K	Buy	+352,084	New	+$836K	0.07%	26
2024 Q1	–	Sell	-4,000	Closed	-$46.7K	–	76
2023 Q4	$46.7K	Buy	+4,000	New	+$53.6K	0.05%	42

Sabby Management's EFTR Position: Q4 2024 in Review

Sabby Management sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q4 2024, closing a stake of 61,758 shares — an estimated $2.29K sold.

Sabby Management first reported a position in EFTR in Q4 2023 and held it in 3 quarters. The position peaked at $102K in Q2 2024. 0 funds tracked by Wall St. Rank hold EFTR as of Q4 2024.

Sabby Management reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Sabby Management sold 61,758 eFFECTOR Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $2.29K.
Sabby Management first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Sabby Management's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $102K in Q2 2024.
0 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Sabby Management's 13F filing for Q4 2024, filed 14 Feb 2025.